Cargando…
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
BACKGROUND: To compare the efficacy and safety of postoperative extensive target volume irradiation with elevated radiation dose and concurrent chemotherapy with radiotherapy only for the postoperative treatment of esophageal squamous cell carcinoma. METHODS: This trial was a single-arm phase II tri...
Autores principales: | Ai, Dashan, Chen, Yun, Liu, Qi, Deng, Jiaying, Zhang, Xiaofei, Zhang, Junhua, Chu, Li, Shen, Jingyi, Ma, Longfei, Zhang, Yawei, Chen, Haiquan, Miao, Longsheng, Zhao, Kuaile, Xiang, Jiaqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903423/ https://www.ncbi.nlm.nih.gov/pubmed/36750858 http://dx.doi.org/10.1186/s13014-023-02211-w |
Ejemplares similares
-
A Phase II Study of Apatinib in Patients with Chemotherapy‐Refractory Esophageal Squamous Cell Carcinoma (ESO‐Shanghai 11)
por: Chu, Li, et al.
Publicado: (2021) -
Dose escalation based on (18)F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)
por: Zhu, Hongcheng, et al.
Publicado: (2022) -
The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
por: Zhang, Xiaofei, et al.
Publicado: (2021) -
A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence
por: Liu, Qi, et al.
Publicado: (2020) -
A nomogram and risk classification model predicts prognosis in Chinese esophageal squamous cell carcinoma patients
por: Deng, Jiaying, et al.
Publicado: (2022)